Division of Addiction Medicine, Department of Emergency Medicine, Case Western Reserve University, Cleveland, Ohio.
J Stud Alcohol Drugs. 2023 Mar;84(2):293. doi: 10.15288/jsad.22-00219. Epub 2022 Nov 7.
Medications for alcohol use disorder (MAUD) are thought to be underused in the United States. This study reviewed data from a national database to determine the frequency of prescribing MAUD for patients admitted to the hospital or discharged with alcohol withdrawal syndromes (AWS).
We searched for hospital admissions from 2019 to 2021 in the Epic Cosmos database associated with an active diagnosis of AWS. We then searched for patients prescribed medications approved for therapy. We reviewed 197,375 admissions with an active diagnosis of AWS.
There was an increasing percentage of admissions for AWS from 2019 to 2021. Overall, only 7% of patients were prescribed MAUD at discharge. Naltrexone was the most prescribed MAUD. Women, non-African Americans, Latinos, and patients under 65 were more likely to be prescribed MAUD.
Many patients with AWS during admission are not prescribed MAUD at the time of discharge.
据认为，在美国，用于治疗酒精使用障碍（MAUD）的药物未得到充分利用。本研究回顾了来自全国数据库的数据，以确定为因酒精戒断综合征（AWS）住院或出院的患者开具 MAUD 的频率。
我们在与 AWS 活跃诊断相关的 Epic Cosmos 数据库中搜索了 2019 年至 2021 年的住院记录。然后，我们搜索了开具批准用于治疗的药物的患者。我们共审查了 197375 例因 AWS 活跃诊断而住院的病例。
从 2019 年到 2021 年，因 AWS 而住院的比例呈上升趋势。总体而言，只有 7%的出院患者被开具 MAUD。纳曲酮是最常被开具的 MAUD。女性、非非裔美国人、拉丁裔和 65 岁以下的患者更有可能被开具 MAUD。
许多在住院期间患有 AWS 的患者在出院时未被开具 MAUD。
